Mijeong Son

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.

Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.

Journal: International journal of molecular sciences

Published: May 14, 2024

Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model.

Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model.

Journal: Intestinal research

Published: September 06, 2022

Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function.

Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function.

Journal: Gut and liver

Published: April 17, 2022

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.

Journal: Pharmaceutics

Published: March 16, 2022

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function.

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function.

Journal: Frontiers in immunology

Published: February 07, 2022

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model.

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model.

Journal: Intestinal research

Published: August 31, 2021

An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways.

An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways.

Journal: Free radical biology & medicine

Published: May 18, 2021

Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice.

Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice.

Journal: Intestinal research

Published: June 23, 2020

Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model.

Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model.

Journal: Journal of nanobiotechnology

Published: May 30, 2020

Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling.

Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling.

Journal: Scientific reports

Published: September 20, 2019

Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human Beings.

Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human Beings.

Journal: Basic & clinical pharmacology & toxicology

Published: October 20, 2016

Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine.

Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine.

Journal: British journal of clinical pharmacology

Published: April 08, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026